I Originalpublikationen Erst - und Letztautorenschaften / equally contributed

Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT.
Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis. 
BMC Nephrol. 2018; 19(1):12.

Faulhaber-Walter R, Scholz S, Haller H, Kielstein JT, Hafer C.
Health status, renal function, and quality of life after multiorgan failure and acute kidney injury requiring renal replacement therapy. 
Int J Nephrol Renovasc Dis. 2016; 9:119-28.

Hafer C, Golla P, Gericke M, Eden G, Beutel G, Schmidt JJ, Schmidt BM, De Reys S, Kielstein JT.
Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study. 
Int Urol Nephrol. 2016; 48(1):133-8.

Schmidt JJ, Jahn J, Golla P, Hafer C, Kielstein JT, Kielstein H.
Effect of therapeutic plasma exchange on plasma levels and total removal of adipokines and inflammatory markers. 
BMC Obes. 2015; 2:37.

Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT.
Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. 
BMC Anesthesiol. 2014; 14:24.

Schmidt JJ, Hafer C, Spielmann J, Hadem J, Schönenberger E, Schmidt BM, Kielstein JT.
Removal characteristics and total dialysate content of glutamine and other amino acids in critically ill patients with acute kidney injury undergoing extended dialysis. 
Nephron Clin Pract. 2014;126(1):62-6.

II Originalpublikationen Co-Autorenschaften

Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallot M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA.
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. 
Int J Antimicrob Agents. 2018; S0924-8579(18)30072-4.

Reising A, Hafer C, Hiss M, Kielstein JT, Menne J, Gueler F, Beneke J, Linnenweber-Held S, Haller H, Einecke G.
Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance. 
Int Urol Nephrol. 2016;48(4):561-70.

Lorenzen JM, Schauerte C, Kielstein JT, Hübner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R, Kumarswamy R, Hafer C, Haller H, Fliser D, Thum T.
Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. 
Clin Chem. 2015; 61(1):191-201.

Hafer C, Kielstein JT.
Pro: High dose of therapeutic plasma exchange-mind the gap! 
Nephrol Dial Transplant. 2017;32(9):1457-1460.

III Case Reports

Eden G, Kühn-Velten WN, Hafer C, Kielstein JT.
Enhanced elimination of cyclophosphamide by high cut-off haemodialysis: single-dose pharmacokinetics in a patient with cast nephropathy. 
BMJ Case Rep.2018. pii: bcr-2017-221735.

Bertram A, Haenel SS, Hadem J, Hoeper MM, Gottlieb J, Warnecke G, Kaschinski S, Hafer C, Kühn-Velten WN, Günther D, Kielstein JT.
Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy. 
BMC Pharmacol Toxicol. 2013;14:45.